This inventor holds 9 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Wisconsin Alumni Research Foundation, The Medical College of Wisconsin, Inc.. Active years: 2010-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
9 out of 4,243 
2 out of 194 
Years Active: 2010-2025
Title: The Innovative Contributions of Bing Yang
Introduction
Bing Yang is a prominent inventor based in Madison, WI (US), known for his significant contributions to the field of cancer research. With a total of 9 patents, he has made strides in identifying biomarkers for prostate cancer, which can lead to improved diagnostic methods and treatment options for patients.
Latest Patents
Bing Yang's latest patents focus on the development of unbiased DNA methylation markers that define extensive field defects in histologically normal prostate tissues associated with prostate cancer. One of his notable patents describes a method for detecting the presence of a prostate cancer field defect in a human subject. This method involves obtaining genomic DNA from the subject and quantifying methylation in specific target regions, including CAV1, EVX1, MCF2L, FGF1, NCR2, WNT2, EXT1, and SPAG4. Significant methylation changes indicate the presence of prostate cancer or a prostate cancer field defect, relative to tissue from a second human subject without prostate cancer.
Another patent outlines a similar method, emphasizing the determination of methylation status in the same target regions. This innovative approach aims to provide new biomarkers for men with prostate cancer, enhancing early detection and treatment strategies.
Career Highlights
Throughout his career, Bing Yang has worked with esteemed organizations such as the Wisconsin Alumni Research Foundation and the Medical College of Wisconsin, Inc. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Bing Yang has collaborated with notable colleagues, including David Frazier Jarrard and Peter LaViolette. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of cancer research.
Conclusion
Bing Yang's contributions to the field of prostate cancer research through his patents and collaborations highlight his dedication to improving patient outcomes. His innovative methods for detecting cancer biomarkers represent a significant advancement in the fight against prostate cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile